Chemical carcinogenesis by DMBA (7,12-dimethylbenzanthracene) in female BALB/c mice: new facts

Polycyclic aromatic hydrocarbons are known carcinogens used in rodent experimental models. In this study, the carcinogen DMBA (7,12-dimethylbenzanthracene) was administered by gavage, diluted in corn oil, to female BALB / c mice at hebdomadary doses of 1 mg per animal for 1, 3, 6 or 9 weeks. Animals...

ver descrição completa

Detalhes bibliográficos
Autores: Oliveira, Krishna Duro de, Avanzo, Gabriela Uliana, Tedardi, Marcello Vannucci, Rangel, Marcelo Monte Mór, Avanzo, José Luis, Fukumasu, Heidge, Rao, Kurapati Venkata Kesava, Sinhorini, Idércio Luiz, Dagli, Maria Lúcia Zaidan
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2015
País:Brasil
Recursos:Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)
Repositório:Brazilian Journal of Veterinary Research and Animal Science
Idioma:inglês
OAI Identifier:oai:revistas.usp.br:article/59426
Acesso em linha:https://www.revistas.usp.br/bjvras/article/view/59426
Access Level:Acceso aberto
Palavra-chave:Carcinogenesis
DMBA
Mice
Lung neoplasms
Breast neoplasms
Carcinogênese
Camundongos
Neoplasias pulmonares
Neoplasias de mama
Descrição
Resumo:Polycyclic aromatic hydrocarbons are known carcinogens used in rodent experimental models. In this study, the carcinogen DMBA (7,12-dimethylbenzanthracene) was administered by gavage, diluted in corn oil, to female BALB / c mice at hebdomadary doses of 1 mg per animal for 1, 3, 6 or 9 weeks. Animals were weighed and monitored weekly until death. Remaining animals were euthanized at the age of 53 weeks. At necropsy, representative fragments of neoplasms were collected and routinely processed for histopathological analysis. Of all mice that received DMBA, 68.57% developed some type of tumor. Of the 70 mice treated with various doses of DMBA, 22 (31.43%) developed mammary tumors. The adenoacanthoma was the most commonly (18.75%) diagnosed histological type of breast cancer. Lung (15.71%), lymphoid tissue (11.43%), stomach (7.14%) and skin (2.86%) were also primary sites of tumor development. One third (33.33%) of the mice receiving 1 mg of DMBA developed lung cancer. Therefore, the administration of DMBA was shown to be an efficient model of carcinogenesis in mice, especially for the study of breast cancer, when using the highest dose, and lung, when using the lowest dose. Carcinogenesis models have been used for several purposes in cancer research. These results represent new facts for a classic carcinogenesis model.